Sperm motility is a critical but under-addressed driver of male infertility. Learn why improving sperm function—not just count—is central to next-generation fertility solutions and strategic acquisition-ready assets.

Biotech leader Roderick Duell explains why validated, de-risked, ready-to-transfer IP is becoming the preferred target for investors and acquirers. Learn how scientific clarity, regulatory preparation, and due-diligence readiness increase valuation and accelerate market entry.

Fertility scientist Dr. Eric Lacy explains how mitochondrial function and ATP generation drive sperm motility — and why innovations like Aqua Fem’s AF compound may redefine male fertility treatments.

Biotech leader Rod Duell explains why male fertility is the most overlooked frontier in reproductive medicine — and how market-ready innovations like Aqua Fem’s AF compound are creating a new billion-dollar category for strategic buyers and investors.

Male fertility plays a critical role in IVF and ART success. Dr. Eric Lacy explains science-backed steps men can take — nutrition, exercise, supplements, reducing toxins, and stress — plus the ideal pre-treatment timeline to improve sperm health and treatment outcomes.

Biotechnology is redefining fertility care—from the lab to the living room. In this thought-leadership article, Rod Duell, CEO of Aqua Fem, examines how emerging innovations in reproductive biology are bridging the gap between cutting-edge science and accessible care. Key topics covered: Advances in male and female fertility biotech The intersection of biotechnology and ART Biotech’s role in cost reduction and accessibility Advocacy’s role in translating science into patient

Male infertility accounts for nearly half of all infertility cases, yet stigma still silences millions. Eric Lacy, PhD, Chief Scientific Officer of Aqua Fem, shares how cultural and clinical shifts can help normalize male fertility discussions and improve outcomes.

In this article, Rod Duell, CEO of Aqua Fem, explores how founders and executives can preserve integrity and purpose while scaling, and why mission alignment is becoming one of the strongest competitive advantages in biotech today.

Discover how modern at-home male fertility testing is evolving—from simple smartphone kits to comprehensive lab-analyzed services by companies like Sapyen, Fellow, and Legacy. Expert insight from Dr. Eric Lacy on accuracy, awareness, and early detection.